POWERFUL 5-IN-1 POST-WORKOUT CREATINE & BCAA FORMULA!
IMPROVED MUSCULAR ATP REGENERATION
Your muscles’ primary source of energy is adenosine triphosphate (ATP). As you train, your ATP levels deplete, causing your muscles to fatigue. Each serving of CELL-TECH™ HYPER-BUILD™ delivers a scientifically studied 5g dose of creatine, which enhances your body’s ability to regenerate ATP, so your muscles keep firing on all cylinders. With better workouts come better results. CELL-TECH HYPER-BUILD will saturate your muscles with creatine, so you can gain more muscle size and strength.
Hultman et al., 1996. Journal of Applied Physiology. 81(1):232-237.
Buford et al., 2007. Journal of the International Society of Sports Nutrition. 4:6.
INCREASED MUSCLE SIZE & STRENGTH
Every scoop of CELL-TECH HYPER-BUILD contains 6g of BCAAs in an optimized 4:1:1 ratio for maximum leucine delivery. Leucine is the most powerful of all amino acids at amplifying protein synthesis and keeping your body anabolic. In fact, the 4g dose found in CELL-TECH HYPER-BUILD has been scientifically shown to increase max strength by over 40% in just 12 weeks! Not only does CELL-TECH HYPER-BUILD deliver more BCAAs than any other creatine formula, it has more than most BCAA formulas too.
Ispoglou et al., 2011. International Journal of Sports Physiology and Performance. 6(1):38-50.
TART CHERRY
CELL-TECH HYPER-BUILD is the only creatine formula on the market that delivers the advanced phytonutrient tart cherry, which is shown in scientific research to improve recovery through the reduction of muscle soreness post-exercise.
You can view this study here: Connolly et al., 2006. British Journal of Sports Medicine. 40:679-683.
BOOST ENDURANCE PERFORMANCE WITH FIRST DOSE
The 1g dose of taurine found in 1 scoop of CELL-TECH HYPER-BUILD is clinically shown to improve performance in endurance athletes. And for those intense workouts, CELL-TECH HYPER-BUILD is also enhanced with electrolytes to help you replace what is lost during exercise.
Balshaw et al., 2013. Amino Acids. 2013. 44(2):555-561.